145 related articles for article (PubMed ID: 4056079)
1. Comparison of two sustained-release theophylline preparations in adult patients with obstructive airways disease.
Harkaway PS; Conlon PF; Hirsh JD; Allen WT
J Clin Pharmacol; 1985 Sep; 25(6):444-7. PubMed ID: 4056079
[TBL] [Abstract][Full Text] [Related]
2. Comparison of aminophylline and theophylline sustained-release formulations by their bioavailability and steady-state serum levels.
Steinijans VW; Zech K; Fischer R
Int J Clin Pharmacol Ther Toxicol; 1983 Dec; 21(12):624-30. PubMed ID: 6668100
[TBL] [Abstract][Full Text] [Related]
3. Comparison of standard- and sustained-release theophylline tablets in patients with chronic obstructive pulmonary disease.
Dasta J; Mirtallo JM; Altman M
Am J Hosp Pharm; 1979 May; 36(5):613-7. PubMed ID: 453214
[No Abstract] [Full Text] [Related]
4. The use of sustained-release theophylline ('Theo-dur') for the treatment of chronic reversible obstructive lung disease in hospital practice.
Riddington CJ; Shipman AJ
Br J Clin Pract; 1985 Apr; 39(4):148-53. PubMed ID: 3893504
[No Abstract] [Full Text] [Related]
5. Absorption of theophylline from conventional and sustained-release tablets.
Fagerström PO; Mellstrand T; Svedmyr N
Int J Clin Pharmacol Ther Toxicol; 1981 Mar; 19(3):131-8. PubMed ID: 7228455
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of theophylline and bioavailability of a sustained release theophylline preparation in patients with cystic fibrosis.
Valet SB; Schwartz RH; Brooks JG
Ann Allergy; 1983 Mar; 50(3):161-5. PubMed ID: 6829982
[TBL] [Abstract][Full Text] [Related]
7. Absorption of theophylline from conventional and sustained-release tablets.
Mellstrand T; Svedmyr N; Fagerström PO
Eur J Respir Dis Suppl; 1980; 109():54-60. PubMed ID: 6934088
[TBL] [Abstract][Full Text] [Related]
8. Bioavailability and pharmacological effects of two slow-release theophylline preparations: intrasubject tablet-to-tablet variability.
Rivera-Calimlim L; Calimlim JF; Liang R; Lasagna L; Diamond GL
J Asthma; 1986; 23(3):113-22. PubMed ID: 3528119
[TBL] [Abstract][Full Text] [Related]
9. [Time-related distribution of delayed-action theophylline in the treatment of chronic obstructive bronchopneumopathies].
Philip-Joet F; Bruguerolle B; Parrel M; Vestri R; Arnaud A
Presse Med; 1988 Feb; 17(5):193-6. PubMed ID: 2965374
[TBL] [Abstract][Full Text] [Related]
10. Absorption properties of two theophylline sustained-release products in smokers.
Miller R; Rheeders M
S Afr Med J; 1984 Jun; 65(26):1045-8. PubMed ID: 6740419
[TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy of once-daily Uniphyl tablets compared with twice-daily Theo-Dur tablets in elderly patients with chronic airflow obstruction.
Rivington RN; Calcutt L; Hodder RV; Stewart JH; Aitken TL
Am J Med; 1988 Jul; 85(1B):48-53. PubMed ID: 3041826
[TBL] [Abstract][Full Text] [Related]
12. Treatment of chronic obstructive pulmonary disease with two sustained-release theophylline preparations.
Giosue S; Bernocchi D; Parola D; Munno R; Mancini P
J Int Med Res; 1987; 15(6):352-60. PubMed ID: 3325318
[TBL] [Abstract][Full Text] [Related]
13. Methods of comparing pharmacokinetics of slow release preparations: a comparison of "Theo-Dur" and "Phyllocontin" in patients with asthma.
Jackson SH; Shah K; Turner P
Eur J Clin Pharmacol; 1986; 30(3):313-7. PubMed ID: 3732367
[TBL] [Abstract][Full Text] [Related]
14. Comparative pharmacokinetic analysis of a novel sustained-release dosage form of theophylline in humans.
Raz I; Bialer M; Salame K; Bar-On H
Eur J Clin Pharmacol; 1984; 26(3):401-3. PubMed ID: 6734702
[TBL] [Abstract][Full Text] [Related]
15. Plasma theophylline concentrations in patients with chronic obstructive airways disease after administration of a new sustained release theophylline formulation.
Taylor DR; Kinney CD; McDevitt DG
Br J Clin Pharmacol; 1982 Apr; 13(4):569-71. PubMed ID: 7066172
[No Abstract] [Full Text] [Related]
16. [Biological availability of two theophylline preparations (author's transl)].
Kaik G
Prax Klin Pneumol; 1982 Jun; 36(6):294-6. PubMed ID: 7111181
[No Abstract] [Full Text] [Related]
17. Serum theophylline levels with oral sustained release theophylline after transfer from intravenous aminophylline in patients with chronic lung disease.
Silins RA; Butcher MA; Marlin GE
Br J Clin Pharmacol; 1984 Oct; 18(4):645-7. PubMed ID: 6487509
[No Abstract] [Full Text] [Related]
18. Serum drug fluctuations after administration of two sustained-release oral theophylline preparations in asthmatic children.
Logvinoff MM; Weinstein DB; Watts MT; Seifert B
Clin Ther; 1986; 8(2):175-80. PubMed ID: 3698064
[TBL] [Abstract][Full Text] [Related]
19. [Optimizing therapy with theophylline preparations in obstructive ventilation disorders. 3. Prediction of theophylline clearance with a simple pharmacokinetic method and comparison of bioavailability of various theophylline retard preparations].
Ranke C; Schmidt G; Oellerich M; Sybrecht GW
Prax Klin Pneumol; 1983 Mar; 37(3):99-108. PubMed ID: 6856564
[No Abstract] [Full Text] [Related]
20. [Possibilities for optimizing therapy with theophylline preparations. I. On the pharmacokinetics of theophylline preparations].
Wiesner B; Sehrt I; Iwainsky H
Z Erkr Atmungsorgane; 1984; 162(1):3-10. PubMed ID: 6719957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
